Closing prices for 09 October 2026
Next earnings report: none scheduled in the next five weeks · Earnings calendar
The series is stated in the current share scale after splits; dividends are not included in the price
Mettler-Toledo International, Inc. trades on NYSE under the ticker MTD. The company belongs to the Health care sector. The trading history on this page starts on 22 August 2016.
Over the past 52 weeks MTD has traded between 1,023 $ and 1,586 $. As of 09 October 2026 the price stood 93.65 % of the way from the 52-week low to the high.
Over one year MTD shares rose 16.67 %; over six months they rose 16.98 %. Volatility over 90 days is 27.12 %. Dividends are not included: this is price change only, as of 09 October 2026.
MTD trades at a price-to-earnings ratio of 37.2, above the sector median of 24.8. Price to sales is 8.0, above the sector median of 3.9. Calculated from reports for the period ending 31 March 2026.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 09 October 2026 | 1,531 | 1,562 | 1,528 | 1,550 | 179,966 |
| 08 October 2026 | 1,522 | 1,537 | 1,501 | 1,529 | 264,500 |
| 07 October 2026 | 1,533 | 1,551 | 1,517 | 1,533 | 227,200 |
| 06 October 2026 | 1,560 | 1,586 |
Based on the last 12 months of reports, through 31 March 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Mettler-Toledo makes precision balances and laboratory instruments — and sells them directly, without distributors.
Its products sit in the laboratories of pharmaceutical and chemical companies, on food production lines and in logistics centres where parcels are weighed. An instrument lasts a decade, while service, calibration and consumables are bought continuously — that is the steady half of revenue.
What sets it apart from competitors is an in-house sales force instead of intermediaries: it costs more but gives direct contact with the customer and an understanding of what they actually need, along with profitability exceptional for the industry. Risks: laboratory capital budgets, biotech start-up funding and demand in China. The company pays no dividend, directing profit into buybacks.
Address:1900 POLARIS PARKWAY, COLUMBUS, OH, 43240, US
Mettler-Toledo International, Inc. reported revenue of 4.1B $ and net income of 875M $ over the last four quarters. Net margin is 21.40 %. Revenue changed by +6.78 % year over year. Earnings per share are 42.57 $. Market capitalisation is 32.5B $.
| 303M |
| TXG10x Genomics, Inc. | 80.65 | +4.36 % | 269M |
| BRKRBruker Corporation | 59.00 | +1.86 % | 137M |
| AVTRAvantor, Inc. | 15.67 | +1.82 % | 130M |
| BIOBio-Rad Laboratories, Inc. | 366.16 | +1.60 % | 98M |
| 1,513 |
| 1,533 |
| 196,000 |
| 05 October 2026 | 1,483 | 1,546 | 1,479 | 1,542 | 167,800 |
| 02 October 2026 | 1,492 | 1,502 | 1,480 | 1,486 | 129,300 |
| 01 October 2026 | 1,534 | 1,534 | 1,474 | 1,481 | 167,700 |
| 30 September 2026 | 1,535 | 1,555 | 1,510 | 1,511 | 152,500 |
| 29 September 2026 | 1,540 | 1,553 | 1,524 | 1,537 | 144,800 |
| 28 September 2026 | 1,489 | 1,545 | 1,485 | 1,545 | 185,000 |
| 25 September 2026 | 1,510 | 1,526 | 1,496 | 1,512 | 129,600 |
| 24 September 2026 | 1,485 | 1,541 | 1,478 | 1,519 | 260,900 |
| 23 September 2026 | 1,485 | 1,513 | 1,482 | 1,492 | 238,600 |
| 22 September 2026 | 1,433 | 1,507 | 1,425 | 1,491 | 302,000 |
| 21 September 2026 | 1,403 | 1,436 | 1,396 | 1,430 | 168,900 |
| 18 September 2026 | 1,405 | 1,416 | 1,385 | 1,392 | 544,400 |
| 17 September 2026 | 1,401 | 1,423 | 1,380 | 1,410 | 288,000 |
| 16 September 2026 | 1,338 | 1,400 | 1,331 | 1,379 | 355,600 |
| 15 September 2026 | 1,293 | 1,336 | 1,285 | 1,330 | 211,700 |
| 14 September 2026 | 1,303 | 1,306 | 1,275 | 1,286 | 206,000 |